Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited at its AGM held on May 15, 2024, approved to consider and approve the proposed appointment of Mr. Zhong Ming as an independent director of the Company effect from the date of the AGM. Following the conclusion of the AGM, the Company announced that Mr. Zhong, who has been appointed as an Independent Director of the Company, will be appointed as a member of the Audit Committee. He is considered by the Board to be independent for the purposes of Rule 704(8) of the Listing Manual.

Ms. Li Qing (Ms. Li), an Independent and Non-Executive Director, retired as a Director of the Company at the conclusion of the AGM as she did not seek re-election. Ms. Li was previously Chairman of the Nomination Committee and a member of the Audit Committee.